Latest Breaking News On - Precigen inc - Page 6 : vimarsana.com

Precigen (NASDAQ:PGEN) Receives New Coverage from Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Precigen (NASDAQ:PGEN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Precigen in a research […]

Cri-Du-Chat Syndrome Treatment Market Would Grow to USD 2,567.33 Million by 2030

The Latest released Cri-Du-Chat Syndrome Treatment Market Research Report provides a detailed assessment of Key and emerging players showcasing company profiles, product/service offerings, market price, and sales revenue to better derive market size estimation. The most appropriate, exclusive, realistic, and admirab...

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday - Adaptive Biotechnologies (NASDAQ:ADPT), Arcutis Biotherapeutics (NASDAQ:ARQT)

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Precigen to Participate in Upcoming Leading Investor and Industry Conferences

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Precigen to Participate in Upcoming Leading Investor and Industry Conferences

Precigen, Inc. (NASDAQ:PGEN) Short Interest Update

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 13,690,000 shares, an increase of 39.4% from the August 15th total of 9,820,000 shares. Based on an average trading volume of 1,670,000 shares, the […]

Precigen, Inc. (NASDAQ:PGEN) SVP Jeffrey Thomas Perez Sells 8,891 Shares

Precigen (NASDAQ:PGEN) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Precigen in […]

StockNews.com Begins Coverage on Precigen (NASDAQ:PGEN)

Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday - American Software (NASDAQ:AMSWA), Affirm Holdings (NASDAQ:AFRM)

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Friday. Here are some big stocks recording gains in today’s session.